West Lafayette, IN, United States of America

Vincent Jo Davisson

USPTO Granted Patents = 10 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 9(Granted Patents)

Location History:

West Lafavette, IN (US) (2012 - 2014)
West Lafayette, IN (US) (2007 - 2024)

Company Filing History:

10 out of 2,660

Purdue Research Foundation

University of Minnesota

patents

where one patent can have more than one assignee

Years Active: 2007-2024

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11884653 - Arylnaphthalene compounds as vacuolar-ATPase inhibitors and the use thereof (2024-01-30),

2. 11542257 - Arylnaphthalene compounds as vacuolar-ATPase inhibitors and the use thereof (2023-01-03),

3. 11400130 - Inhibitors for proliferating cell nuclear antigen and uses (2022-08-02),

4. 10760113 - Kinase activity detection methods (2020-09-01),

5. 10758588 - Inhibitors for proliferating cell nuclear antigen and uses (2020-09-01),

6. 9970878 - Higher order structured dyes with enhanced optical features (2018-05-15),

7. 9190099 - Higher order structured dyes with enhanced optical features (2015-11-17),

8. 8765950 - Reagents for biomolecular labeling, detection and quantification employing raman spectroscopy (2014-07-01),

9. 8153827 - Reagents for biomolecular labeling, detection and quantification employing Raman spectroscopy (2012-04-10),

10. 7283228 - Process and apparatus for segregation and testing by spectral analysis of solid deposits derived from liquid mixtures (2007-10-16),

Title: The Innovative Mind of Vincent Jo Davisson

Introduction

Vincent Jo Davisson, an accomplished inventor based in West Lafayette, IN, has made significant contributions to the field of pharmaceutical science. With a portfolio of ten patents, Davisson has focused much of his work on developing novel compounds aimed at treating severe viral infections, particularly those caused by filoviruses such as Ebola and Marburg virus.

Latest Patents

Among his latest innovations, Vincent Jo Davisson has patented arylnaphthalene compounds designed as vacuolar-ATPase inhibitors. These compounds show promise for treating a broad spectrum of viral infections, including devastating filovirus outbreaks, which have a fatality rate of up to 90%. The relevance of his work is underscored by the recent outbreak in West Africa that led to over 11,000 deaths. The patents disclose pharmaceutical compositions and methods of use for these novel compounds, further advancing public health efforts against these severe viral threats.

Career Highlights

Davisson's career is marked by his significant affiliation with prominent research institutions, including the Purdue Research Foundation and the University of Minnesota. His work at these institutions has laid the groundwork for numerous advances in antiviral therapies. With a focus on innovative solutions, Davisson has consistently aimed to address critical health challenges through his inventive prowess.

Collaborations

Throughout his career, Vincent Jo Davisson has collaborated with talented researchers such as Meiguo Xin and Shirshendu K. Deb. These collaborative efforts have enriched his research and expanded the potential applications of his inventions in the pharmaceutical industry.

Conclusion

Vincent Jo Davisson exemplifies the innovative spirit that drives progress in the field of medical science. With a robust portfolio of patents and a commitment to addressing urgent health issues, his contributions continue to create a positive impact on global health. His work not only showcases his inventive capabilities but also highlights the importance of collaboration in the pursuit of scientific advancement.

This text is generated by artificial intelligence and may not be accurate.